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osting by EAbstract HCV-RNA in saliva of HCV patients provides a biological basis for its potential trans-
mission. HCV viremia is particularly high in HCV patients on hemodialysis. This study aimed to
evaluate the prevalence of HCV in saliva of HCV patients with and without renal failure, and
the possible role of intrafamilial transmission of the virus.
Twenty HCV patients were enrolled in this study. They were divided into two groups: 10 HCV-
infected patients without renal failure (Group I) and 10 with renal failure (Group II). Detection
of HCV-RNA by quantitative RT-PCR in serum and saliva of both groups was done. Thirty-eight
family members of both groups were included for the detection of serum HCV antibody. The per-
centage of the saliva-positive patients for HCV was signiﬁcantly higher in the renal failure group
(70%) than the other group (40%) (p< 0.05). There was insigniﬁcant statistical difference between
the two groups as regards infectivity to their family contacts.
Also there was insigniﬁcant correlation between the level of viremia and the intra familial transmis-
sion with a mean + SD (9,33,250 + 24,501) in negative relatives and a mean + SD(79,912+26,879)173033559.
om (M.M. Sayed).
y. Production and hosting by
Shams University.
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88 H. El Tayeb et al.in positive relatives (p> 0.05). But a signiﬁcant correlation was revealed between the level of viremia
and saliva positivity, with a mean + SD(12,95,666 + 1792) in saliva-positive patients and a
mean + SD (3,74,465 + 2150) in saliva-negative patients (p< 0.05). There was a highly signiﬁcant
difference between infectivity of HCV saliva-positive patients and saliva-negative patients to their
family contacts (p< 0.001).
Conclusion: Increased percentage of HCV detection in saliva of HCV patients with renal failure on
HDmay cause spreading of HCV in HD units among RF patients. Also there was increased percent-
age of interfamilial infectivity among the saliva-positive patients to their relatives and this suggests
that saliva might have an infective role.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) infection represents a major public
health problem in the world today. Egypt has possibly the
highest HCV prevalence in the world; 10–20% of the general
populations are infected and HCV is the leading cause of
hepatocellular carcinoma (HCC) and chronic liver disease
in the country [1–3]. Approximately 90% of Egyptian HCV
isolates belongs to a single genotype, 4a, which responds less
successfully to interferon (IFN) therapy than other genotypes
[1].
Epidemiological surveys demonstrate that body ﬂuids other
than blood, including saliva, might be the potential sources of
HCV infection. Several studies have demonstrated HCV-RNA
in the saliva of hepatitis C patients by reverse transcription
(RT)-nested PCR. However, the detection rates of viral
RNA within saliva have varied widely since the efﬁciency of
HCV transmission is likely related to its viral load. It is impor-
tant to quantitate viral RNA levels within body ﬂuids in order
to properly evaluate the possible non-parenteral routes of
HCV infection. [4].
Although sexual and vertical transmissions have also been
reported, there remains a large number of HCV carriers in
whom no route of infection has been identiﬁed [5]. The poten-
tial infectivity of body ﬂuids in HCV-positive-infected patients
has been identiﬁed by the detection of HCV-RNA in saliva,
ascites, breast milk, urine, feces, semen and cervico-vaginal
secretions [6].
Poor oral hygiene, with gingivitis and oral mucosal lesions
can cause the exudation of serum into the saliva and increase
the shedding of potentially infected mononuclear cells into
the salivary pool, but interestingly neither factor correlated
with the presence of HCV-RNA in saliva [7].
Some HCV-RNA particles could appear in the saliva as a
result of active HCV replication in the salivary glands. This
could explain the HCV-RNA sequences found in serum and
oral tissues in some patients, the detection of different geno-
types in serum and in saliva of a single patient [7], and the exis-
tence of patients who are serum negative but saliva positive for
HCV [8].
Dialysis patients have an increased risk of exposure to
parentally transmitted hepatitis viruses. The prevalence of
HCV among hemodialysis patients is highly variable between
different countries and between different centers in the same
locality [9].
Duration of hemodialysis, past history of blood transfu-
sions, and alanine aminotransferase (ALT) elevations correlate
with higher rates of anti-HCV positivity. Molecular virological
studies have clearly shown the nosocomial transmission ofHCVto hemodialysis patients, but the exact modes of transmission
remain unclear. Studies suggest several risk factors, including
transmission through blood components; patient-to-patient
transmission through shared equipment, devices, or multidose
vials; and between patients treated on the same shift but not
sharing equipment [10].
Possible contamination by HCV was studied by collecting
environmental samples in a hemodialysis unit. Samples and
controls were tested for HCV-RNA, by qualitative transcrip-
tion-mediated ampliﬁcation assay. The HCV-RNA-positive
samples were found in the dialysis unit on the external surface
of the dialysate (inlet–outlet) connector of a dialysis machine
used for HCV-negative patients.[11].
2. Aim of the study
The aim of the present study was to evaluate the correlation
of HCV load in saliva of HCV patients with and without re-
nal failure and its effect on intrafamilial transmission of the
virus.
3. Subjects and methods
Twenty patients with HCV were enrolled in this study. They
were attending in Ain Shams University Hospitals outpatient
clinic or admitted in internal medicine department in the per-
iod from March 2007 to July 2007. Thirty-eight of their fam-
ily members were included in this study after their verbal
consent.
3.1. Patient group
The patients were classiﬁed into two groups as follows:
Group I: This group included 10 patients with hepatitis C
virus positive without renal failure (RF).
Group II: This group included 10 patients with hepatitis C
virus positive with chronic renal failure on hea-
modialysis for 3–5 years in 80% of them and over
5 years in 20%.
3.2. Family group
Included 38 family members, their ages ranged between 7 and
73 years with a mean ± SD (37.97 ± 15.4). Rapid chromato-
graphic immunoassay for qualitative detection of antibody to
HCV in serum or plasma using one step Test Device was done
to this group.
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1. Full detailed history including risk factors.
2. Full clinical examination.
3. Laboratory investigations include: liver function tests [total
and direct bilirubin, aspartate transaminase (AST), alanine
transaminase (ALT), serum albumin, total protein], renal
function tests [serum creatinine and blood urea nitrogen
(BUN)], complete blood count (CBC), prothrombin time
(PT) and partial thromboplastin time (PTT), serum electro-
lytes [sodium and potassium (Na&K)].
4. Abdominal ultrasonography.
5. Detection of HCV-RNA: patients spit into a cup to obtain
saliva samples. Whole saliva samples (approximately 2 ml)
were then transferred into sterile containers. All samples
were macroscopically observed to exclude samples contain
blood. Detection of HCV-RNA by using Quantitative
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR) in serum and saliva of the patient group.4. Extraction of viral RNA
Viral RNA was extracted from the sera of patients using viral
RNA extraction kit supplied by (QIAGEN) according to man-
ufacturer’s instruction. All RNA preparation and handling
steps took place in a laminar ﬂow hood, under RNAse-free
conditions. The isolated RNA was resuspended in RNAse-free
water and stored at 80 C until assay. The RNA concentra-
tion was assessed by absorbance reading at 260 nm with UV
spectrophotometry (Beckman; Du series 650, Inc., USA).
4.1. Ampliﬁcation by one step RT-PCR
RT-PCR reactions were performed using Qiagen one step RT-
PCR kit. A total amount of 50 ll reaction solution contained
16 ll RNAse-free water, 10 ll 5· Qiagen one step RT-PCR
buffer, 2 ll dNTP mix, 5 ll of forward primer, 5 ll of reverse
primer, 2 ll of Qiagen one step RT-PCR Enzyme mix, 10 ll of
template RNA.
Primers sequence were: forward primer (50-CTT T CG
CGACCCAAC ACT AC-30) and reverse primer (50-AGC
GCC ATA GTG GTC TGC GG-30).
Thermocycling was carried out in an MJ Research PTC 200
(MJ Research, Inc., Boston, MA) according to the follow-
ing cycling proﬁles; 50 C for 30 min, 95 C for 15 min, then
40 cycles of 94 C for 1 min, 55 C for 1 min, 72 C for
1 min, then 72 C for 10 min, ﬁnally hold on 4 C.
The expected PCR product for HCV is 270 base pair on 2%
agarose gel.
Quantiﬁcation of PCR products of both serum and saliva
samples was performed using UVP GEL DOCUMENT
System.
4.2. Exclusion criteria
1. Toxic habits as alcohol consumption and recreational
drugs.
2. Concomitant hepatic diseases.
Analysis of data was done by IBM computer using SPSS
(statistical program for social science version 12) as follows: Description of quantitative variables as mean, SD and
range.
 Description of qualitative variables as number and
percentage.
 Chi-square test was used to compare qualitative variables
between groups.
 Fisher exact test was used instead of chi-square test when
one expected cell or more are less than or equal to 5.P value >0.05 was insigniﬁcant.
P< 0.05 was signiﬁcant.
P< 0.001 was highly signiﬁcant.5. Results and discussion
In the present study, the patients were divided into two groups:
Group I included 10 patients with hepatitis C virus positive
without renal failure (RF) of whom 5 (50%) were males and
5 (50%) were females. Their ages ranged between 26 and
53 years with a mean + SD (40.4 + 10). Four of them
(40%) were married for more than 15 years and 6 (60%) were
married for less than 15 years. Also 9 (90%) were nonsmokers
while 1 (10%) was a smoker and Group II which included 10
patients with hepatitis C virus positive with chronic renal fail-
ure on hemodialysis for 3–5 years in 80% of them and over
5 years in 20%. They were 4 (40%) males and 6 (60%) females.
Their ages ranged between 30 and 74 years with a mean + SD
(48.7 + 13). Six (60%) were married for more than 15 years
and 4 (40%) were married for less than 15 years. Also 7
(70%) were nonsmokers and 3 (30%) were smokers. Another
group which is a family group included 38 family members,
their ages ranged between 7 and 73 years with a mean ± SD
(37.97 ± 15.4).
There was insigniﬁcant difference (P> 0.05) as regards age,
gender, duration of marriage and smoking between the two
groups. Abdominal ultrasound showed 3 (30%) were normal,
5 (50%) had mild hepatomegaly and 2 (20%) had cirrhosis in
Group I (HCV +ve only) while in Group II (HCV + RF) 7
(70%) had mild hepatomegaly and 3 (30%) had cirrhosis.
The results of our study were shown in Tables 1–9 as fol-
lows: Table 1 showed a highly statistically signiﬁcant difference
between both groups as regards bilharziasis and blood transfu-
sion. Table 2 showed highly signiﬁcant difference in viral load
in group one patients with pcr positive saliva. Table 3 showed
highly signiﬁcant difference in viral load in group two patients
with pcr positive saliva. Table 4 showed comparison as regards
PCR titer in HCV patients in relation to positive family mem-
bers and showed insigniﬁcant difference. Table 5 showed that
the number and percentage of relative affected are same in
both groups. Table 6 showed a highly statistical signiﬁcant dif-
ference between HCV +ve relatives and HCV –ve relatives as
regards the saliva positivity of the infected patients by using
chi square test. Table 7 showed a highly statistical signiﬁcant
difference between the two groups with as regards the positiv-
ity of their relatives for HCV by using Fisher exact test. Table
8 showed a statistically signiﬁcant difference between both
groups as regards AST, and a highly statistically signiﬁcant
difference between both groups as regards ALT by using chi-
square test. Table 9 showed a statistically signiﬁcant difference
between both groups as regards saliva positivity by using
Fisher exact test.
In this study the percentage of the saliva-positive patients
for HCV by RT-PCR was signiﬁcantly higher in the renal fail-
Table 1 Comparison between both groups as regards past
history and exposure risk factors.
Variables HCV(10) HCV(10) + RF P
Bilharziasis (B)
Yes 5(50%) 9(90%) <0.05*
No 5(50%) 1(10%)
Injection treatment for B
No 6(60%) 8(80%) >0.05
Yes 4(40%) 2(20%)
Tablets treatment for B
No 7(70%) 9(90%) >0.05
Yes 3(30%) 1(10%)
Operations
No 0 1(10%) >0.05
Yes 10(10%) 9(90%)
Blood transfusion
No 9(90%) 3(30%) <0.01**
Yes 1(10%) 7(70%)
Tooth extraction
No 2(20%) 2(20%) >0.05
Yes 8(80%) 8(80%)
Pinprick injury
No 7(70%) 10(100%) <0.05*
Yes 3(30%) 0
Sharing house tools
No 1(10%) 0 >0.05
Yes 9(90%) 10(100%)
Tooth brush sharing
No 10(100%) 10(100%) >0.05
Yes 0 0
* Signiﬁcant test.
** Highly signiﬁcant test.
Table 2 Comparison as regards PCR titer in HCV patient (10
pts) without renal failure in relation to presence of HCV in
saliva.
Variable Mean PCR titer (IU) ±SD P
Negative saliva 2,75,366 ±2305.51 <.001
Positive saliva 12,15,206 ±1700.22
Table 3 Comparison as regards PCR titer in HCV patient on
HD in relation to presence of HCV in saliva.
Variable Mean PCR titer (IU) ±SD Z P
Negative saliva 37,465 ±2150 2.2 <0.05*
Positive saliva 12,95,666 ±1792
* Signiﬁcant test.
Table 4 Comparison as regards PCR titer in HCV patients in
relation to positive family members.
Relatives Mean (IU) ±SD Z P
Negative (12 relatives) 9,33,250 ±24501 1.8 >0.05
Positive (3 relatives) 79,912 ±26879
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(Table 9), taking into consideration that the patients did not
suffer from bleeding per gums and there was no RBCs detected
in the saliva samples, which may indicate the effect of hemod-
ialysis and renal failure as a type of immuno-suppression to se-
crete HCV in saliva.In comparison to a study done by Patrı´cia et al. [12] where
HCV-RNA was detected in saliva samples from 8 out of 32
(25%) patients with detectable plasmatic HCV-RNA. The
genotype found in the saliva samples was the same as that ob-
served in the plasma samples. No correlation was found be-
tween the presence of HCV-RNA in the saliva, and gender,
risk factors or clinical presentation of HCV infection.
This also agrees with a study done by Lock et al. [13] where
in nine patients (30%), the saliva before tooth brushing was
positive for HCV-RNA, and in 11 patients (36.7%) HCV-
RNA was detected in the saliva after tooth brushing. Five of
these 11 patients tested negative for saliva samples before
tooth brushing.
In this study it was found that 8 familial contacts out of 38
total familial contacts were positive to HCV with over all per-
centage (21%) with insigniﬁcant difference between the studied
groups as regards intrafamilial transmission (Table 5).
This is also conﬁrmed by Fabris et al. [14] where HCV-
RNA was detectable in the cell fraction of saliva in a high pro-
portion of highly viremic patients with chronic hepatitis C.
In this study 6 out of 26 (children and brother and sisters)
were positive with the prevalence of 23% which shows impor-
tance of intrafamilial transmission by the non sexual route and
possibility of genetic factor or other unknown risk factors.
This agrees with a study done by Mostafa et al. [15] which
revealed that Egyptian children from rural communities whose
parents had antibodies to HCV (anti-HCV) were at higher risk
for having anti-HCV than children whose parents did not. The
association was greater with mothers than fathers and when
the parent had positive HCV-RNA.
There was insigniﬁcant correlation between the level of vire-
mia and the intrafamilial transmission (Table 4) and this was
in agreement with a study done by Keiserman et al. [16] who
concluded that there was low prevalence of intrafamilial trans-
mission of HCV, independent of HCV/HIV co infection and
the viral load of HCV did not affect to spread in family.
There was a signiﬁcant correlation between the level of vire-
mia and saliva positivity in these patients but there was no cut-
off value predicting the shedding of the virus in saliva where
one patient with low viremia had the virus positive in her saliva
while some other patients who had high to moderate viremia
were saliva negative.
Regarding the genotype of HCV, it was 4a in serum and
saliva of patients and their positive relatives.
This was compared with another study done by Michael
Carter [17] where the strongest predictor of shedding was
HCV serum viral load. No patients shed HCV in their saliva
if they had a serum HCV viral load below 1 million copies/
ml. Having an HCV viral load 1-log higher increased 40-fold
the likelihood of the virus being shed in the saliva (P< .0001).
In comparison to another study done by Liliane Lins et al.
[18] there was no correlation found between HCV-RNA in sal-
iva, oral health, and viral load. These results suggested that
Table 8 Relation of abnormality of liver enzymes (ALT,
AST) with HCV spread in family contacts.
Variable AST in
positive
relatives
AST in
negative
relatives
ALT in
positive
relatives
ALT in
negative
relatives
Mean 76 IU 42.7 IU 133 34.9
SD 25.7 11.7 75.1 10.2
P <0.05* <0.01**
* Signiﬁcant test.
** Highly signiﬁcant test.
Table 7 Relationship between saliva-positive pts and positive
HCV relatives in both groups.
Variable Saliva +ve
HCV pts
Saliva +ve
RF pts
P
Positive relatives 2 4 <0.01**
Negative relatives 5 12
** Highly signiﬁcant test.
Table 5 Comparison between both groups as regards the
positivity of the relatives.
Relatives HCV patients
without RF
HCV patients
with RF
Positive relatives 4(21%) 4(21%)
Negative relatives 15(79%) 15(79%)
Total 19 19
Table 9 Relationship between saliva-positive patients in the
two groups.
Saliva HCV pts HCV+ RF pts P
Saliva positive 4 7 <0.05*
Saliva negative 6 3
* Signiﬁcant test.
Table 6 Relationship between saliva-positive patients and
HCV +ve relatives.
Saliva by PCR HCV +ve relatives HCV –ve relatives P
Saliva +ve pts 6 17 <0.01**
Saliva –ve pts 2 13
** Highly signiﬁcant test.
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load and the oral pathology of HCV positive individuals.
In this study, there was a high signiﬁcant difference between
infectivity of HCV saliva-positive patients and saliva-negative
patients to their family contacts, 11 saliva-positive patients had
6 out of 23 relatives were positive, i.e. 26% were infected, 9 sal-
iva-negative patients had 2 out of 15 relatives were positive, i.e.13% were infected (P< 0.01), which shows the possible role
of saliva as an important route of infection. (Tables 6 and 7).
In this study we found a high statistical signiﬁcance be-
tween the degree of elevation of liver enzymes (ALT, AST)
and the liability of infectivity to family contacts, being higher
in positive HCV relatives than negative one This may show a
correlation between the virus activity in the patient, and the
infectivity of that patient to his family members, also the
importance of different pathogenic factors as well as patient
factors (Table 9).
5.1. Bilharzial infection as a risk factor for HCV infection
In this study there was a high statistically signiﬁcant difference
between both groups as regards bilharzial infection. This signi-
ﬁes the importance of bilharzial infection as a source of HCV
infection here in Egypt.
This agrees with Abdollah et al. [19] where the history of
parenteral treatment for Schistosomiasis was observed to clus-
ter within households, OR for clustering: 2.44 (95% CI: 1.47–
4.06). Overall, HCV sero-positivity was 40% (321/796) and
was observed to cluster within households that had members
who had received parenteral treatment for Schistosomiasis
(Table 1).
5.1.1. A case study
In this study there was a case of saliva-positive HCV by RT-
PCR, although the serum was negative for PCR (taking into
consideration that it was positive 4 months ago) which shows
the ﬂuctuation of the HCV viremia and the possibility of the
virus to remain dormant in the salivary glands causing infectiv-
ity to other family members in spite of being serum HCV neg-
ative, and that HCV can directly infect the salivary glands.6. Conclusion
In this study we found increased percentage of HCV detection
in saliva in HCV-infected patients with renal failure on HD
possibly due to the effect of immuno-suppression in these
patients, which may cause spreading of HCV in HD units
among RF patients in spite of taking the standard precautions.
Also we found that there is increased percentage of infectivity
among the saliva-positive patients to their relatives than
saliva-negative patients and this suggests that saliva might
have an infective role and additional way of intrafamilial
spread of the virus.Conﬂict of interest
No one of the authors have conﬂict of interest regarding this
paper.
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